Accutane blood donors
Executive Summary
FDA sent a memo to all establishments collecting blood, blood components and source plasma advising them to defer any donor taking Accutane for at least one month from receipt of the last dose of the drug. "If a donor who is receiving Accutane (isotretinoin) gives blood, and the donated blood is transfused into a patient who either is or soon becomes pregnant, there may be a risk to the developing fetus because of Accutane in the transfused blood," FDA warns.
You may also be interested in...
DJO Thinks Trilliant Is Brilliant, Announces Acquisition
DJO Global will buy Trilliant Surgical to further its ongoing expansion into the US foot and ankle market.
Legend Biotech CEO Ying Huang On Moving Fast In the BCMA CAR-T Race
Ying Huang was named CEO as his predecessor came under investigation in China and as partner Janssen was getting closer to seeking US FDA approval for its lead CAR-T therapy.
Brazil Authorizes Oxford/AZ and Sinovac Vaccines
In addition to agreeing to emergency use of the Oxford University/Astra Zeneca and Sinovac vaccines, Brazil's medicines regulator has also published good manufacturing practices certificates for Pfizer and Janssen vaccine. It has questions about the Sputnik V authorization request.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: